Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor

J Cyst Fibros. 2022 Mar;21(2):e102-e105. doi: 10.1016/j.jcf.2022.01.005. Epub 2022 Jan 19.

Abstract

Aquagenic wrinkling of palms (AWP) in cystic fibrosis (CF) patients and common CFTR mutations is recognized as a frequent symptom of the disease. The long-term effect of CFTR targeting therapy on AWP has not been studied. AWP was monitored in 16 CF patients (8 children and 8 adults) before and for 6 months after initiation of ivacaftor therapy. Thirteen (81.3%) patients had at least mild and 8/16 (50%) moderate-to-severe AWP at baseline. AWP improved with ivacaftor therapy. This observation suggests that AWP is also common in individuals with CF and relatively rare mutations and is directly related to CFTR function.

Keywords: Aquagenic Wrinkling; Cystic fibrosis; Ivacaftor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aminophenols / pharmacology
  • Aminophenols / therapeutic use
  • Child
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Mutation
  • Quinolones
  • Skin Aging / drug effects
  • Skin Aging / genetics
  • Water / adverse effects

Substances

  • Aminophenols
  • Quinolones
  • Water
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • ivacaftor